Spinal Cord Research Help
AboutCategoriesLatest ResearchContact
Subscribe
Spinal Cord Research Help

Making Spinal Cord Injury (SCI) Research Accessible to Everyone. Simplified summaries of the latest research, designed for patients, caregivers and anybody who's interested.

Quick Links

  • Home
  • About
  • Categories
  • Latest Research
  • Disclaimer

Contact

  • Contact Us
© 2025 Spinal Cord Research Help

All rights reserved.

  1. Home
  2. Research
  3. Spinal Cord Injury
  4. Tanshinone IIA improves functional recovery in spinal cord injury-induced lower urinary tract dysfunction

Tanshinone IIA improves functional recovery in spinal cord injury-induced lower urinary tract dysfunction

Neural Regeneration Research, 2017 · DOI: 10.4103/1673-5374.200810 · Published: February 1, 2017

Spinal Cord InjuryUrologyPharmacology

Simple Explanation

This study investigates the potential of Tanshinone IIA (TIIA), a compound from Salvia miltiorrhiza Bunge, to improve lower urinary tract (LUT) function after spinal cord injury (SCI) in rats. Rats with SCI were treated with TIIA, and their bladder function, spinal cord regeneration, and nerve cell health were compared to those treated with methylprednisolone (MP), a standard treatment, and a control group. The findings suggest that TIIA can improve bladder function and promote spinal cord regeneration, potentially offering a new treatment approach for SCI-induced LUT dysfunction.

Study Duration
4 weeks
Participants
80 female Sprague-Dawley rats
Evidence Level
Not specified

Key Findings

  • 1
    TIIA reduced inflammation and edema in the bladder tissue of SCI rats.
  • 2
    TIIA improved urodynamic parameters, such as voided volume and voiding efficiency, in SCI rats.
  • 3
    TIIA reduced the number of apoptotic dorsal root ganglion cells.

Research Summary

This study investigates the effects of Tanshinone IIA (TIIA) on lower urinary tract (LUT) dysfunction in a rat model of spinal cord injury (SCI). The results indicate that TIIA treatment improves bladder function, reduces inflammation, and promotes spinal cord regeneration after SCI. The findings suggest that TIIA may be a potential therapeutic agent for SCI-induced LUT dysfunction, offering an alternative to methylprednisolone with potentially fewer side effects.

Practical Implications

Potential Therapeutic Agent

Tanshinone IIA may serve as a potential therapeutic agent for SCI-induced LUT dysfunction.

Alternative Treatment Option

TIIA could be an alternative to methylprednisolone with potentially fewer side effects.

Spinal Pathway Remodeling

TIIA has great potential in remodeling the spinal pathway related to LUT control.

Study Limitations

  • 1
    The study was conducted on rats, and further research is needed to confirm these findings in humans.
  • 2
    The exact mechanisms by which TIIA improves bladder function and promotes spinal cord regeneration require further investigation.
  • 3
    There were no dramatic differences between TIIA group and MP group

Your Feedback

Was this summary helpful?

Back to Spinal Cord Injury